Biotechnology Progress·Jan 23Engineering a high-throughput clone for industrial-scale production of long-acting GLP-1 analogue with retained bio-efficacyExperiments in bacteriaGLP-1 receptor agonistsPaper
The Journal of Clinical Endocrinology and Metabolism·Dec 18Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and TirzepatideSystematic reviewGLP-1 receptor agonistsPaper
Visceral Medicine·Dec 12Gastrointestinal Motility Function and Dysfunction in the Elderly Patient: What Are the Effects of Aging?ReviewMechanismsPaper
The Journal of Endocrinology·Dec 10The role of glucagon-like peptides in osteosarcopeniaReviewOsteosarcopeniaPaper
International Journal of Pharmaceutics·Dec 8Tracking the journey: Gastrointestinal transit and intraluminal pH dynamics in aging populations using wireless motility capsuleCohort study of 30 peopleMechanismsPaper
Critical Reviews in Food Science and Nutrition·Nov 27Impact of aging on the digestive system related to protein digestion in vivoReviewMechanismsPaper
Diabetes, Obesity & Metabolism·Nov 26Why does GLP-1 agonist combined with GIP and/or GCG agonist have greater weight loss effect than GLP-1 agonist alone in obese adults without type 2 diabetes?ReviewGLP-1 receptor agonistsPaper
Endocrinology·Nov 26Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal MotilityReviewGut and microbiomePaper
British Journal of Anaesthesia·Nov 21Glucagon-like peptide-1 receptor agonists and impaired gastric emptying: a pharmacovigilance analysis of the US Food and Drug Administration adverse event reporting systemStudy of 1,982 peopleGLP-1 receptor agonistsPaper
Annals of Plastic Surgery·Sep 4Glucagon-Like Peptide-1 Agonists: A Practical Overview for Plastic and Reconstructive SurgeonsReviewGLP-1 receptor agonistsPaper
Obesity Pillars·Aug 31Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risksSystematic reviewGLP-1 receptor agonistsPaper
Medicinal Research Reviews·Aug 14Incretin-based therapies for the management of cardiometabolic disease in the clinic: Past, present, and futureReviewCardiometabolic diseasePaper
World Journal of Diabetes·Aug 5Management of gestational diabetes mellitus via nutritional interventions: The relevance of gastric emptyingCommentaryLifestyle interventionPaper
The Lancet Gastroenterology & Hepatology·Aug 1Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directionsReviewGLP-1 receptor agonistsPaper
European Journal of Pharmaceutical Sciences·Jul 22Impact of advanced age on the gastric emptying of water under fasted and fed state conditionsStudy in peopleMechanismsPaper
European Journal of Medicinal Chemistry·Mar 17Glucagon-like peptide-1 analogs: Miracle drugs are blooming?ReviewInterventionsPaper
Biomedicine & Pharmacotherapy·Jan 18Efficacy and safety of GLP-1RAs for people with obesity: A systematic review based on RCT and Bayesian network meta-analysisMeta-analysis of randomized trialsObesityPaper
JBJS Reviews·Jan 5Glucagon-like Peptide-1 Agonists: What the Orthopaedic Surgeon Needs to KnowReviewGLP-1 receptor agonistsPaper
Journal of Orthopaedic Surgery and Research·Dec 15The association between oral carbohydrate intake before orthopedic surgery for osteoporotic fractures and outcomes in elderly patientsCohort study of 879 peopleOsteoporotic fracturesPaper
Cardiology in Review·Oct 20Cagrilintide: A Long-Acting Amylin Analog for the Treatment of ObesityReviewObesityPaper
Theranostics·Sep 29Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonistsReviewGLP-1 receptor agonistsPaper
Diabetes & Metabolism·Sep 2GLP-1 receptor agonists effect on cognitive function in patients with and without type 2 diabetesReviewGLP-1 receptor agonistsPaper
Diabetes, Obesity & Metabolism·Apr 27A randomized Phase I study of the safety, tolerability, pharmacokinetics and pharmacodynamics of BI 456906, a dual glucagon receptor/glucagon-like peptide-1 receptor agonist, in healthy Japanese men with overweight/obesityRandomized trial in 36 peopleObesityPaper
EClinicalMedicine·Mar 20Pharmacotherapy of obesity: an update on the available medications and drugs under investigationReviewObesityPaper
Diabetes, Obesity & Metabolism·Jan 26Effects of co-ingesting glucose and whey protein on blood glucose, plasma insulin and glucagon concentrations, and gastric emptying, in older men with and without type 2 diabetesNon-randomized trial in peopleGlucosePaper
American Journal of Therapeutics·Dec 13Tirzepatide: A Dual Glucose-dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Agonist for the Management of Type 2 Diabetes MellitusReviewGLP-1 receptor agonistsPaper
International Journal of Molecular Sciences·Nov 23Tirzepatide: A Systematic UpdateSystematic reviewTirzepatidePaper
Food Chemistry·Oct 1Impact of elderly gastrointestinal alterations on gastric emptying and enzymatic hydrolysis of skim milk: An in vitro study using a dynamic stomach systemExperiments in cellsMechanismsPaper
Arquivos de Gastroenterologia·Jul 14GASTROINTESTINAL MOTILITY IN ELDERLY PATIENTS WITH WELL-CONTROLLED TYPE 2 DIABETES MELLITUSCohort study of 30 peopleMechanismsPaper